Evidence map›Paper›PMID 36143881›Full record

ArticleMedicina (Kaunas, Lithuania)2022

Malassezia Folliculitis following Triple Therapy for Cystic Fibrosis.

Federica Li Pomi, Luca Di Bartolomeo, Mario Vaccaro, Maria Lentini, Simona Cristadoro, Maria Cristina Lucanto, Mariangela Lombardo, Stefano Costa, Francesco Borgia

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Federica Li PomiDepartment of Clinical and Experimental Medicine, Section of Dermatology, University of Messina, 98122 Messina, Italy.ORCID 0000-0001-6760-9468
Luca Di BartolomeoDepartment of Clinical and Experimental Medicine, Section of Dermatology, University of Messina, 98122 Messina, Italy.ORCID 0000-0002-5457-6246
Mario VaccaroDepartment of Clinical and Experimental Medicine, Section of Dermatology, University of Messina, 98122 Messina, Italy.ORCID 0000-0003-3787-5145
Maria LentiniDepartment of Human Pathology of Adult and Childhood Gaetano Barresi, University of Messina, 98122 Messina, Italy.
Simona CristadoroCystic Fibrosis Center, Gastroenterology and Cystic Fibrosis Unit, Department of Human Pathology of Adult and Childhood Gaetano Barresi, University of Messina, 98122 Messina, Italy.
Maria Cristina LucantoCystic Fibrosis Center, Gastroenterology and Cystic Fibrosis Unit, Department of Human Pathology of Adult and Childhood Gaetano Barresi, University of Messina, 98122 Messina, Italy.
Mariangela LombardoCystic Fibrosis Center, Gastroenterology and Cystic Fibrosis Unit, Department of Human Pathology of Adult and Childhood Gaetano Barresi, University of Messina, 98122 Messina, Italy.
Stefano CostaCystic Fibrosis Center, Gastroenterology and Cystic Fibrosis Unit, Department of Human Pathology of Adult and Childhood Gaetano Barresi, University of Messina, 98122 Messina, Italy.
Francesco BorgiaDepartment of Clinical and Experimental Medicine, Section of Dermatology, University of Messina, 98122 Messina, Italy.ORCID 0000-0003-3515-8441
University of Messina · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Triple-combination therapy with elexacaftor, tezacaftor and ivacaftor has been recently approved for cystic fibrosis patients with at least one F508

Indexed as

Cystic FibrosisFolliculitisMalasseziaAminophenolsCystic Fibrosis Transmembrane Conductance RegulatorDrug CombinationsFemaleHumansMutationQuinolonesAminophenolsCystic Fibrosis Transmembrane Conductance RegulatorDrug CombinationsivacaftorQuinolonesadverse drug reactioncystic fibrosiselexacaftor/tezacaftor/ivacaftorfolliculitisMalasseziamicrobiomeskin

Identifiers

PMID36143881
PMCPMC9503821
OpenAlexW4294176892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.